Working… Menu

A Multicenter Study of the Efficacy and Safety of JZP-258 in the Treatment of Idiopathic Hypersomnia (IH) With an Open-label Safety Extension

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03533114
Recruitment Status : Completed
First Posted : May 22, 2018
Last Update Posted : June 11, 2021
Information provided by (Responsible Party):
Jazz Pharmaceuticals

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : June 12, 2020
Actual Study Completion Date : December 18, 2020
Certification/Extension First Submitted : June 4, 2021